CD44 Variant 6 in Endometrioid Carcinoma of the Uterus: Its Expression in the Adenocarcinoma Component is an Independent Prognostic Marker-Reference-Cited by-同舟云学术

CD44 Variant 6 in Endometrioid Carcinoma of the Uterus: Its Expression in the Adenocarcinoma Component is an Independent Prognostic Marker

Published:2003-01 Issue:2 Volume:199 Page:71-77
ISSN:0344-0338
Container-title:Pathology - Research and Practice
language:en
Short-container-title:Pathology - Research and Practice

Author:

Hoshimoto Kazufusa,Yamauchi Naoko,Takazawa Yutaka,Onda Takashi,Taketani Yuji,Fukayama Masashi

Publisher

Elsevier BV

Subject

Cell Biology,Pathology and Forensic Medicine

Reference22 articles.

1. Surgical pathologic spread patterns of endometrial cancer. A Gynecologic Oncology Group Study;Creasman;Cancer,1987

2. Importance of different CD44v6 expression in human gastric intestinal and diffuse type cancers for metastatic lymphogenic spreading;Dammrich;J Mol Med,1995

3. Announcements

4. Expression of CD44 in normal human versus tumor endometrial tissues: possible implication of reduced expression of CD44 in lymph-vascular space involvement of cancer cells;Fujita;Cancer Res,1994

5. CD44: a multitude of isoforms with diverse functions;Gunthert;Curr Top Microbiol Immunol,1993

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association of high expression of CD44 in clinicopathological factors of endometrial cancer;Minerva Obstetrics and Gynecology;2023-03

2. Cell adhesion molecules in endometrial cancer – A systematic review;Advances in Medical Sciences;2019-09

3. CD44ICD promotes breast cancer stemness via PFKFB4-mediated glucose metabolism;Theranostics;2018

4. Unsupervised Clustering of Immunohistochemical Markers to Define High-Risk Endometrial Cancer;Pathology & Oncology Research;2017-12-20

5. Expression of CD44 variant 6 and its prognostic value in benign and malignant endometrial tissue;Archives of Gynecology and Obstetrics;2017-06-15